Glycopyrrolate is an anticholinergic medication used to reduce excess secretions in the body, including saliva, sweat, stomach acid, and airway mucus. It works by blocking a chemical messenger called acetylcholine from activating specific receptors on muscles and glands, which dials down fluid production in those tissues. Because it affects several organ systems, glycopyrrolate has a surprisingly wide range of medical uses, from managing drooling in children with neurological conditions to helping people with COPD breathe more easily.
How Glycopyrrolate Works
Your nervous system uses acetylcholine to trigger glands and smooth muscles throughout the body. Glycopyrrolate blocks the receptors that acetylcholine binds to, particularly a subtype called M3 receptors, which are the primary drivers of airway constriction and glandular secretions. By occupying those receptors first, the drug prevents acetylcholine from doing its job, so glands produce less fluid and smooth muscles relax.
One notable feature of glycopyrrolate is that it barely crosses into the brain. Its molecular structure carries a permanent electrical charge that makes it difficult to pass through fatty membranes, including the blood-brain barrier. This means it causes far fewer cognitive side effects (confusion, drowsiness, memory problems) than older anticholinergic drugs. That distinction matters especially for elderly patients, who are more vulnerable to brain-related side effects from this drug class.
Chronic Drooling in Children
Glycopyrrolate is FDA-approved to treat chronic, severe drooling (sialorrhea) in children ages 3 to 16 with neurological conditions such as cerebral palsy. These children often have difficulty controlling their oral muscles, which leads to persistent drooling that can cause skin irritation, social difficulties, and increased risk of aspiration. The oral liquid form of glycopyrrolate reduces saliva production enough to manage the problem without sedating the child, since the drug stays out of the central nervous system.
COPD Maintenance Therapy
In its inhaled form, glycopyrrolate is approved for long-term maintenance treatment of chronic obstructive pulmonary disease. It belongs to a class called long-acting muscarinic antagonists, which are one of the two main pillars of COPD management (the other being a different type of bronchodilator called a long-acting beta-agonist). Inhaled glycopyrrolate specifically targets the M3 receptors in the airways that cause them to tighten and produce excess mucus.
Clinical evidence shows it improves lung function, reduces the frequency of flare-ups, and eases breathlessness, all of which translate to a measurable improvement in quality of life. It acts quickly compared to some other drugs in its class, making it useful for patients who need prompt symptom relief alongside long-term control. It’s available on its own and in combination inhalers that pair it with other bronchodilators or anti-inflammatory medications for people who need more than one drug to keep their symptoms managed.
Excessive Underarm Sweating
A topical form of the drug (glycopyrronium tosylate, sold as a medicated cloth wipe) is approved for primary axillary hyperhidrosis, the medical term for excessive underarm sweating that isn’t caused by another condition or medication. Clinical trials showed it reduces both patient-reported severity and the measurable volume of sweat produced, with improvements sustained through 48 weeks of treatment. For people whose daily lives are disrupted by sweating through shirts or avoiding social situations, this provides a targeted option that stays on the skin rather than circulating through the entire body.
Reducing Secretions Before Surgery
Anesthesiologists commonly use glycopyrrolate before and during surgery to dry up secretions in the mouth, throat, and airways. This serves a practical purpose: less fluid in the airway means clearer visibility when placing a breathing tube and a lower risk of the patient inhaling saliva or mucus into the lungs during the procedure. A typical adult dose given by injection before anesthesia effectively suppresses secretions from salivary glands, bronchial glands, and the pharynx. It also helps stabilize heart rate during anesthesia, since some anesthetic drugs and procedures can trigger a reflexive slowing of the heart that glycopyrrolate counteracts.
Peptic Ulcers
Glycopyrrolate’s original approved use was as an add-on treatment for peptic ulcers in adults. By blocking acetylcholine receptors in the stomach lining, it reduces acid production and slows gut motility, which can help an ulcer heal. In practice, this use has largely been replaced by more effective acid-suppressing drugs like proton pump inhibitors, but it remains an approved indication.
Common Side Effects
Because glycopyrrolate reduces secretions broadly, its side effects are predictable extensions of that same action. Dry mouth is the most frequently reported, since the drug suppresses saliva production regardless of which condition it’s being used for. Other common effects include constipation (from slowed gut movement), blurred vision, decreased sweating, flushing, and urinary retention. Reduced sweating is worth paying attention to in hot weather or during exercise, since it can increase the risk of overheating.
Tachycardia, a faster-than-normal heart rate, can also occur because the drug blocks the nerve signals that normally keep heart rate in check. Most of these effects are mild and dose-dependent, meaning they tend to be more noticeable at higher doses and less pronounced with the topical or inhaled forms that deliver the drug to a specific area rather than the whole body.
Who Should Not Take It
Glycopyrrolate is not safe for everyone. It is contraindicated in people with angle-closure glaucoma, because blocking acetylcholine can increase pressure inside the eye. It should also be avoided in several gastrointestinal conditions where slowing gut movement would be dangerous: bowel obstruction, paralytic ileus (a condition where the intestines stop moving), severe ulcerative colitis, toxic megacolon, and reflux esophagitis. People with a hiatal hernia or intestinal atony, particularly older or debilitated patients, are also advised against using it. Anyone with a known allergy to glycopyrronium or other anticholinergic drugs should not take it in any form.